ONCR || GI: Pancreatic

Biomarker correlates with pancreatic cancer severity

Posted on: 29/04/2015 - 22:12

HOUSTON – A circulating biomarker has the potential to identify metastatic pancreatic cancer and may be able to predict prognosis, investigators sai... More »

Field of Interest: Gastroentero...

Type: News Item

Biomarker correlates with pancreatic cancer severity

Posted on: 29/04/2015 - 22:12

HOUSTON – A circulating biomarker has the potential to identify metastatic pancreatic cancer and may be able to predict prognosis, investigators sai... More »

Field of Interest: Oncology

Type: News Item

AACR: Metformin survival benefit shaky in pancreatic cancer

Posted on: 22/04/2015 - 18:31

A detailed survival analysis questions the rationale behind use of the diabetes drug metformin to improve pancreatic cancer survival. Several epidemi... More »

Field of Interest: Oncology

Type: News Item

MicroRNA test improved preop pancreatic cancer diagnosis

Posted on: 01/10/2014 - 08:00

Cytology and a microRNA-based test identified pancreatic cancer 91% of the time in specimens obtained by endoscopic ultrasound-guided fine-needle aspiration – a substantial improvement, compared with...

Field of Interest: Gastroentero...

Type: News Item

MicroRNA test improved preop pancreatic cancer diagnosis

Posted on: 01/10/2014 - 08:00

Field of Interest: Oncology

Type: News Item

Pancreatic cancer predicted to become second-leading cause of U.S. cancer deaths by 2030

Posted on: 20/05/2014 - 20:50

If current trends hold true, pancreatic and liver cancer will overtake breast and colorectal cancer to become the second- and third-most-common causes of cancer-related deaths in the United States by...

Field of Interest: Oncology

Type: News Item

Biomarker correlates with pancreatic cancer severity

Biomarker correlates with pancreatic cancer severity

AACR: Metformin survival benefit shaky in pancreatic cancer

MicroRNA test improved preop pancreatic cancer diagnosis

MicroRNA test improved preop pancreatic cancer diagnosis

Pancreatic cancer predicted to become second-leading cause of U.S. cancer deaths by 2030

Newsletters

Latest Newsletters

You are here

ONCR || GI: Pancreatic

Biomarker correlates with pancreatic cancer severity

Biomarker correlates with pancreatic cancer severity

AACR: Metformin survival benefit shaky in pancreatic cancer

MicroRNA test improved preop pancreatic cancer diagnosis

MicroRNA test improved preop pancreatic cancer diagnosis

Pancreatic cancer predicted to become second-leading cause of U.S. cancer deaths by 2030

Newsletters

Latest Newsletters